• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病的放射学评估

Radiologic evaluation of nonalcoholic fatty liver disease.

作者信息

Lee Seung Soo, Park Seong Ho

机构信息

Seung Soo Lee, Seong Ho Park, Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul 138-736, South Korea.

出版信息

World J Gastroenterol. 2014 Jun 21;20(23):7392-402. doi: 10.3748/wjg.v20.i23.7392.

DOI:10.3748/wjg.v20.i23.7392
PMID:24966609
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4064084/
Abstract

Nonalcoholic fatty liver disease (NAFLD) is a frequent cause of chronic liver diseases, ranging from simple steatosis to nonalcoholic steatohepatitis (NASH)-related liver cirrhosis. Although liver biopsy is still the gold standard for the diagnosis of NAFLD, especially for the diagnosis of NASH, imaging methods have been increasingly accepted as noninvasive alternatives to liver biopsy. Ultrasonography is a well-established and cost-effective imaging technique for the diagnosis of hepatic steatosis, especially for screening a large population at risk of NAFLD. Ultrasonography has a reasonable accuracy in detecting moderate-to-severe hepatic steatosis although it is less accurate for detecting mild hepatic steatosis, operator-dependent, and rather qualitative. Computed tomography is not appropriate for general population assessment of hepatic steatosis given its inaccuracy in detecting mild hepatic steatosis and potential radiation hazard. However, computed tomography may be effective in specific clinical situations, such as evaluation of donor candidates for hepatic transplantation. Magnetic resonance spectroscopy and magnetic resonance imaging are now regarded as the most accurate practical methods of measuring liver fat in clinical practice, especially for longitudinal follow-up of patients with NAFLD. Ultrasound elastography and magnetic resonance elastography are increasingly used to evaluate the degree of liver fibrosis in patients with NAFLD and to differentiate NASH from simple steatosis. This article will review current imaging methods used to evaluate hepatic steatosis, including the diagnostic accuracy, limitations, and practical applicability of each method. It will also briefly describe the potential role of elastography techniques in the evaluation of patients with NAFLD.

摘要

非酒精性脂肪性肝病(NAFLD)是慢性肝病的常见病因,范围从单纯性脂肪变性到非酒精性脂肪性肝炎(NASH)相关的肝硬化。尽管肝活检仍是诊断NAFLD的金标准,尤其是诊断NASH,但成像方法已越来越多地被接受为肝活检的非侵入性替代方法。超声检查是一种成熟且经济高效的成像技术,用于诊断肝脂肪变性,特别是用于筛查大量有NAFLD风险的人群。超声检查在检测中重度肝脂肪变性方面具有合理的准确性,尽管其在检测轻度肝脂肪变性方面准确性较低,依赖操作者,且较为定性。计算机断层扫描不适用于对一般人群进行肝脂肪变性评估,因为其在检测轻度肝脂肪变性方面不准确且存在潜在辐射危害。然而,计算机断层扫描在特定临床情况下可能有效,例如评估肝移植供体候选人。磁共振波谱和磁共振成像现在被认为是临床实践中测量肝脏脂肪最准确的实用方法,尤其是对于NAFLD患者的纵向随访。超声弹性成像和磁共振弹性成像越来越多地用于评估NAFLD患者的肝纤维化程度,并区分NASH和单纯性脂肪变性。本文将综述目前用于评估肝脂肪变性的成像方法,包括每种方法的诊断准确性、局限性和实际适用性。还将简要描述弹性成像技术在评估NAFLD患者中的潜在作用。

相似文献

1
Radiologic evaluation of nonalcoholic fatty liver disease.非酒精性脂肪性肝病的放射学评估
World J Gastroenterol. 2014 Jun 21;20(23):7392-402. doi: 10.3748/wjg.v20.i23.7392.
2
Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病患者肝脏疾病的无创评估。
Gastroenterology. 2019 Apr;156(5):1264-1281.e4. doi: 10.1053/j.gastro.2018.12.036. Epub 2019 Jan 18.
3
Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.肝活检及非侵入性诊断测试在非酒精性脂肪性肝病/非酒精性脂肪性肝炎诊断中的局限性
World J Gastroenterol. 2014 Jan 14;20(2):475-85. doi: 10.3748/wjg.v20.i2.475.
4
Current and Emerging Biomarkers and Imaging Modalities for Nonalcoholic Fatty Liver Disease: Clinical and Research Applications.当前和新兴的非酒精性脂肪性肝病生物标志物和影像学手段:临床和研究应用。
Clin Ther. 2021 Sep;43(9):1505-1522. doi: 10.1016/j.clinthera.2021.07.012. Epub 2021 Aug 13.
5
Assessment of Imaging Modalities Against Liver Biopsy in Nonalcoholic Fatty Liver Disease: The Amsterdam NAFLD-NASH Cohort.非酒精性脂肪性肝病中肝活检与影像学方法的评估:阿姆斯特丹非酒精性脂肪性肝病-非酒精性脂肪性肝炎队列。
J Magn Reson Imaging. 2021 Dec;54(6):1937-1949. doi: 10.1002/jmri.27703. Epub 2021 May 15.
6
MR elastography is effective for the non-invasive evaluation of fibrosis and necroinflammatory activity in patients with nonalcoholic fatty liver disease.磁共振弹性成像可有效用于非酒精性脂肪性肝病患者肝纤维化和坏死性炎症活动的无创评估。
Eur J Radiol. 2018 Jan;98:82-89. doi: 10.1016/j.ejrad.2017.11.003. Epub 2017 Nov 11.
7
Nonalcoholic Fatty Liver Disease and Staging of Hepatic Fibrosis.非酒精性脂肪性肝病与肝纤维化分期。
Adv Exp Med Biol. 2024;1460:539-574. doi: 10.1007/978-3-031-63657-8_18.
8
Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.磁共振成像比瞬时弹性成像更能准确地对非酒精性脂肪性肝病患者的脂肪变性和纤维化进行分类。
Gastroenterology. 2016 Mar;150(3):626-637.e7. doi: 10.1053/j.gastro.2015.11.048. Epub 2015 Dec 8.
9
Diagnosis of Non-alcoholic Fatty Liver Disease (NAFLD): Current Concepts.非酒精性脂肪性肝病 (NAFLD) 的诊断:现状。
Curr Pharm Des. 2018;24(38):4574-4586. doi: 10.2174/1381612825666190117102111.
10
Imaging evaluation of non-alcoholic fatty liver disease: focused on quantification.非酒精性脂肪性肝病的影像学评估:重点在于定量分析。
Clin Mol Hepatol. 2017 Dec;23(4):290-301. doi: 10.3350/cmh.2017.0042. Epub 2017 Oct 10.

引用本文的文献

1
The association between cardiometabolic index (CMI) and metabolic dysfunction-associated steatotic liver disease (MASLD): a systematic review and meta-analysis.心脏代谢指数(CMI)与代谢功能障碍相关脂肪性肝病(MASLD)之间的关联:一项系统评价和荟萃分析。
Diabetol Metab Syndr. 2025 Aug 30;17(1):364. doi: 10.1186/s13098-025-01912-4.
2
Markers of body fat, the mediating role of alanine aminotransferase, and their association with the risk of metabolic dysfunction-associated steatotic liver disease.体脂标志物、丙氨酸氨基转移酶的中介作用及其与代谢功能障碍相关脂肪性肝病风险的关联。
Eur J Pediatr. 2025 Aug 2;184(8):524. doi: 10.1007/s00431-025-06332-0.
3
Preperitoneal fat thickness as a potential noninvasive marker for metabolic-associated liver disease: A retrospective study.腹膜前脂肪厚度作为代谢相关肝病的潜在非侵入性标志物:一项回顾性研究。
Medicine (Baltimore). 2025 Jul 25;104(30):e43584. doi: 10.1097/MD.0000000000043584.
4
Steatotic Liver Disease in Older Adults: Clinical Implications and Unmet Needs.老年人脂肪性肝病:临床意义与未满足的需求
Nutrients. 2025 Jun 30;17(13):2189. doi: 10.3390/nu17132189.
5
Correlation between gynecomastia and endocrine regulation in patients with metabolic dysfunction-associated fatty liver disease: A cross-sectional study.代谢功能障碍相关脂肪性肝病患者男性乳腺增生与内分泌调节的相关性:一项横断面研究。
World J Hepatol. 2025 Jun 27;17(6):108096. doi: 10.4254/wjh.v17.i6.108096.
6
Attenuation Based Quantitative Evaluation of Hepatic Steatosis Using US: Current Status and Future Perspective.基于衰减的肝脏脂肪变性超声定量评估:现状与未来展望
J Korean Soc Radiol. 2025 May;86(3):321-334. doi: 10.3348/jksr.2025.0024. Epub 2025 May 26.
7
Metabolic dysfunction-associated steatotic liver disease in people with HIV.HIV感染者中与代谢功能障碍相关的脂肪性肝病
Curr Opin HIV AIDS. 2025 Jul 1;20(4):350-358. doi: 10.1097/COH.0000000000000952. Epub 2025 May 21.
8
Increased Hepatorenal Index Is Associated with the Risk of Developing Stroke in Patients with Nonalcoholic Fatty Liver Disease.肝肾指数升高与非酒精性脂肪性肝病患者发生中风的风险相关。
Curr Med Sci. 2025 May 7. doi: 10.1007/s11596-025-00051-1.
9
Dynamic Status of Systemic Immune Inflammation Index Is Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease: An Evidence From a Ten-Year Prospective Longitudinal Cohort Study.全身免疫炎症指数的动态状态与代谢功能障碍相关脂肪性肝病有关:一项十年前瞻性纵向队列研究的证据
J Inflamm Res. 2025 Apr 1;18:4595-4606. doi: 10.2147/JIR.S509814. eCollection 2025.
10
Associations between cardiometabolic indices and the onset of metabolic dysfunction-associated steatotic liver disease as well as its progression to liver fibrosis: a cohort study.心脏代谢指标与代谢功能障碍相关脂肪性肝病的发病及其向肝纤维化进展之间的关联:一项队列研究
Cardiovasc Diabetol. 2025 Apr 3;24(1):154. doi: 10.1186/s12933-025-02716-6.

本文引用的文献

1
What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome?非酒精性脂肪性肝病作为代谢综合征的新标准如何?
World J Gastroenterol. 2013 Jun 14;19(22):3375-84. doi: 10.3748/wjg.v19.i22.3375.
2
Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials.磁共振成像与组织学在非酒精性脂肪性肝病临床试验中定量评估肝脏脂肪变化的效用。
Hepatology. 2013 Dec;58(6):1930-40. doi: 10.1002/hep.26455. Epub 2013 Oct 17.
3
Community-based lifestyle modification programme for non-alcoholic fatty liver disease: a randomized controlled trial.基于社区的生活方式改变方案治疗非酒精性脂肪性肝病:一项随机对照试验。
J Hepatol. 2013 Sep;59(3):536-42. doi: 10.1016/j.jhep.2013.04.013. Epub 2013 Apr 23.
4
Is Assessing the Presence of NASH by Liver Histology or Surrogate Markers Always Advisable?通过肝脏组织学或替代标志物评估非酒精性脂肪性肝炎的存在总是明智的吗?
Hepat Mon. 2013 Feb 20;13(2):e7560. doi: 10.5812/hepatmon.7560. Print 2013 Feb.
5
Is fatty liver always benign and should not consequently be treated?脂肪肝总是良性的,因此不应该治疗吗?
J Physiol Pharmacol. 2013 Feb;64(1):3-9.
6
The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease.地中海饮食可改善非酒精性脂肪肝患者的肝脂肪变性和胰岛素敏感性。
J Hepatol. 2013 Jul;59(1):138-43. doi: 10.1016/j.jhep.2013.02.012. Epub 2013 Feb 26.
7
Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis.非酒精性脂肪性肝病:MR 成像肝脏质子密度脂肪分数评估肝脂肪变性。
Radiology. 2013 May;267(2):422-31. doi: 10.1148/radiol.12120896. Epub 2013 Feb 4.
8
Sonographic hepatorenal ratio: a noninvasive method to diagnose nonalcoholic steatosis.超声肝肾比:一种诊断非酒精性脂肪变性的非侵入性方法。
J Clin Ultrasound. 2013 Jan;41(1):18-25. doi: 10.1002/jcu.21994. Epub 2012 Sep 20.
9
Non-invasive determination of hepatic steatosis by acoustic structure quantification from ultrasound echo amplitude.基于超声回波幅度的声学结构定量分析无创性检测肝脂肪变
World J Gastroenterol. 2012 Aug 7;18(29):3889-95. doi: 10.3748/wjg.v18.i29.3889.
10
Quantification of hepatic steatosis with dual-energy computed tomography: comparison with tissue reference standards and quantitative magnetic resonance imaging in the ob/ob mouse.双能 CT 定量检测肝脂肪变:与组织参考标准和肥胖型糖尿病(ob/ob)小鼠定量磁共振成像的比较。
Invest Radiol. 2012 Oct;47(10):603-10. doi: 10.1097/RLI.0b013e318261fad0.